Form 4: Cencora CEO Sells Shares After Option Exercise
Insider Transaction Report
Cencora's President & CEO, Robert P. Mauch, exercised stock options and subsequently sold a portion of his common stock holdings under a Rule 10b5-1 plan.
Summary
- Robert P. Mauch, President & CEO and Director of Cencora, Inc. (COR), reported transactions on January 20, 2026.
- Mauch acquired 3,763 shares of Cencora Common Stock by exercising non-qualified stock options at a price of $86.09 per share.
- Following the option exercise, Mauch sold 5,096 shares of Cencora Common Stock at an average price of $354.73 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan.
- After these transactions, Mauch directly owns 66,726 shares of Cencora Common Stock and 3,762 non-qualified stock options.
Sentiment
Score: 6
Explanation: The filing reports routine insider transactions (option exercise and subsequent sale) executed under a pre-arranged Rule 10b5-1 plan. While an insider sale reduces direct equity exposure, the pre-planned nature mitigates negative sentiment, and the significant difference between exercise and sale price indicates strong stock performance.
Positives
- The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales and reducing concerns about insider trading based on non-public information.
- The exercise price of the options ($86.09) is significantly lower than the sale price ($354.73), indicating substantial value creation for the executive.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived neutrally to slightly negatively by the market as it reduces the executive's direct equity stake.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May observe a slight reduction in direct insider ownership, but the 10b5-1 plan suggests a routine financial planning event rather than a lack of confidence.
Key Dates
| Date | Description |
|---|---|
| 11/13/2020 | First installment date for option exercisability. |
| 11/13/2021 | Second installment date for option exercisability. |
| 11/13/2022 | Third installment date for option exercisability. |
| 11/13/2023 | Fourth installment date for option exercisability. |
| 01/20/2026 | Date of stock option exercise and common stock sale. |
| 01/22/2026 | Date the Form 4 was signed. |
| 11/13/2026 | Expiration date of non-qualified stock options. |
Recommendation
holdThe filing details a routine insider transaction involving the exercise of stock options and a subsequent sale of shares under a Rule 10b5-1 plan. This type of transaction is typically pre-scheduled and does not inherently signal a change in the company's fundamental outlook or the executive's confidence. While it reduces the executive's direct share count, the pre-planned nature and the significant profit realized from the option exercise suggest a personal financial planning event rather than a bearish signal. Therefore, the filing itself does not provide new information to warrant a change in investment recommendation, maintaining a 'hold' position based on existing company fundamentals.
Keywords
Cencora, COR, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Robert P. Mauch, CEO, Director, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.